COMPANY OVERVIEW

Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of immune system to treat solid tumors.

---

LOCATION

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Immunology

Oncology

---

WEBSITE

https://oncorus.com

---

CAREER WEBSITE

https://oncorus.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jul 16, 2020

Oncorus Announces Clinical Trial Collaboration with Merck to Evaluate the Combination of Oncorus’ ONCR-177 with Merck’s KEYTRUDA (pembrolizumab)...

Jul 16, 2020

Oncorus Initiates First-in-Human Phase 1 Study of ONCR-177 for the Treatment of Adult Subjects with Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors

Dec 20, 2019

Oncorus Appoints Mary Kay Fenton to its Board of Directors

Dec 3, 2019

Oncorus to Present at 31st Annual Piper Jaffray Healthcare Conference

Oct 22, 2019

John McCabe Joins Oncorus, Inc. as Chief Financial Officer

For More Press Releases

---